<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Chron Obstruct Pulmon Dis</journal-id><journal-id journal-id-type="iso-abbrev">Int J Chron Obstruct Pulmon Dis</journal-id><journal-id journal-id-type="publisher-id">International Journal of COPD</journal-id><journal-title-group><journal-title>International Journal of Chronic Obstructive Pulmonary Disease</journal-title></journal-title-group><issn pub-type="ppub">1176-9106</issn><issn pub-type="epub">1178-2005</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26648705</article-id><article-id pub-id-type="pmc">4648595</article-id><article-id pub-id-type="doi">10.2147/COPD.S91176</article-id><article-id pub-id-type="publisher-id">copd-10-2423</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>The one repetition maximum test and the sit-to-stand test in the assessment of a specific pulmonary rehabilitation program on peripheral muscle strength in COPD patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zanini</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="af1-copd-10-2423">1</xref><xref ref-type="aff" rid="af2-copd-10-2423">2</xref><xref ref-type="corresp" rid="c1-copd-10-2423"/></contrib><contrib contrib-type="author"><name><surname>Aiello</surname><given-names>Marina</given-names></name><xref ref-type="aff" rid="af3-copd-10-2423">3</xref></contrib><contrib contrib-type="author"><name><surname>Cherubino</surname><given-names>Francesca</given-names></name><xref ref-type="aff" rid="af1-copd-10-2423">1</xref></contrib><contrib contrib-type="author"><name><surname>Zampogna</surname><given-names>Elisabetta</given-names></name><xref ref-type="aff" rid="af1-copd-10-2423">1</xref></contrib><contrib contrib-type="author"><name><surname>Azzola</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="af4-copd-10-2423">4</xref></contrib><contrib contrib-type="author"><name><surname>Chetta</surname><given-names>Alfredo</given-names></name><xref ref-type="aff" rid="af3-copd-10-2423">3</xref></contrib><contrib contrib-type="author"><name><surname>Spanevello</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="af1-copd-10-2423">1</xref><xref ref-type="aff" rid="af5-copd-10-2423">5</xref></contrib></contrib-group><aff id="af1-copd-10-2423"><label>1</label>Division of Pneumology, IRCCS Rehabilitation Institute of Tradate, Salvatore Maugeri Foundation, Tradate, Italy</aff><aff id="af2-copd-10-2423"><label>2</label>Division of Internal and Respiratory Medicine, Malcantonese Hospital, Giuseppe Rossi Foundation, Castelrotto, Switzerland</aff><aff id="af3-copd-10-2423"><label>3</label>Respiratory Disease and Lung Function Unit, Department of Clinical and Experimental Medicine, University of Parma, Padiglione Rasori, Parma, Italy</aff><aff id="af4-copd-10-2423"><label>4</label>Division of Pneumology, Department of Internal Medicine, Ospedale Civico, Lugano, Switzerland</aff><aff id="af5-copd-10-2423"><label>5</label>Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy</aff><author-notes><corresp id="c1-copd-10-2423">Correspondence: Andrea Zanini, Divisione di Medicina Interna a Indirizzo Pneumologico, Ospedale Malcantonese, Fondazione Giuseppe Rossi, 6980 Castelrotto, Switzerland, Tel +41 91 611 3700, Fax +41 91 611 3701, Email <email>azanini67@gmail.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>11</day><month>11</month><year>2015</year></pub-date><volume>10</volume><fpage>2423</fpage><lpage>2430</lpage><permissions><copyright-statement>&#x000a9; 2015 Zanini et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License</copyright-statement><copyright-year>2015</copyright-year><license><license-p>The full terms of the License are available at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p></license></permissions><abstract><sec><title>Background</title><p>Individuals with COPD may present reduced peripheral muscle strength, leading to impaired mobility. Comprehensive pulmonary rehabilitation (PR) should include strength training, in particular to lower limbs. Furthermore, simple tools for the assessment of peripheral muscle performance are required.</p></sec><sec><title>Objectives</title><p>To assess the peripheral muscle performance of COPD patients by the sit-to-stand test (STST), as compared to the one-repetition maximum (1-RM), considered as the gold standard for assessing muscle strength in non-laboratory situations, and to evaluate the responsiveness of STST to a PR program.</p></sec><sec><title>Methods</title><p>Sixty moderate-to-severe COPD inpatients were randomly included into either the specific strength training group or into the usual PR program group. Patients were assessed on a 30-second STST and 1-minute STST, 1-RM, and 6-minute walking test (6MWT), before and after PR. Bland&#x02013;Altman plots were used to evaluate the agreement between 1-RM and STST.</p></sec><sec><title>Results</title><p>The two groups were not different at baseline. In all patients, 1-RM was significantly related to the 30-second STST (<italic>r</italic>=0.48, <italic>P</italic>&#x0003c;0.001) and to 1-minute STST (<italic>r</italic>=0.36, <italic>P</italic>=0.005). The 30-second STST was better tolerated in terms of the perceived fatigue (<italic>P</italic>=0.002) and less time consuming (<italic>P</italic>&#x0003c;0.001) test. In the specific strength training group significant improvements were observed in the 30-second STST (<italic>P</italic>&#x0003c;0.001), 1-minute STST (<italic>P</italic>=0.005), 1-RM (<italic>P</italic>&#x0003c;0.001), and in the 6MWT (<italic>P</italic>=0.001). In the usual PR program group, significant improvement was observed in the 30-second STST (<italic>P</italic>=0.042) and in the 6MWT (<italic>P</italic>=0.001).</p></sec><sec><title>Conclusion</title><p>Our study shows that in stable moderate-to-severe inpatients with COPD, STST is a valid and reliable tool to assess peripheral muscle performance of lower limbs, and is sensitive to a specific PR program.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>sit-to-stand test</kwd><kwd>strength training</kwd><kwd>COPD</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Muscle weakness and peripheral muscle dysfunction are highly prevalent comorbidities of chronic obstructive pulmonary disease (COPD), contributing to exercise intolerance and symptom intensity.<xref rid="b1-copd-10-2423" ref-type="bibr">1</xref>,<xref rid="b2-copd-10-2423" ref-type="bibr">2</xref> Pulmonary rehabilitation (PR) has a well-established role in the management of COPD patients with peripheral muscle dysfunction.<xref rid="b3-copd-10-2423" ref-type="bibr">3</xref> Evidence-based guidelines for PR recommend that the exercise component of the program includes endurance and strength training of the lower limbs.<xref rid="b4-copd-10-2423" ref-type="bibr">4</xref> Strength training has a greater potential to improve muscle mass and strength than with endurance training.<xref rid="b5-copd-10-2423" ref-type="bibr">5</xref>,<xref rid="b6-copd-10-2423" ref-type="bibr">6</xref> In addition, strength training also induces less dyspnea during the exercise period, making this strategy better performed by patients with moderate-to-severe COPD, than with aerobic training.<xref rid="b7-copd-10-2423" ref-type="bibr">7</xref></p><p>The one-repetition maximum (1-RM) strength test is defined as the maximal weight that can be lifted once by proper lifting technique<xref rid="b8-copd-10-2423" ref-type="bibr">8</xref>,<xref rid="b9-copd-10-2423" ref-type="bibr">9</xref> using a resistance machine. 1-RM is considered as the gold standard for assessing muscle strength in non-laboratory situations.<xref rid="b8-copd-10-2423" ref-type="bibr">8</xref>,<xref rid="b9-copd-10-2423" ref-type="bibr">9</xref> The 1-RM is a well-tolerated test by patients included in PR programs<xref rid="b10-copd-10-2423" ref-type="bibr">10</xref> and has been recently used to evaluate the muscle strength assessment in individuals with COPD.<xref rid="b11-copd-10-2423" ref-type="bibr">11</xref>,<xref rid="b12-copd-10-2423" ref-type="bibr">12</xref> However, the test requires trained personnel and equipment, with unavoidable expenditure in terms of time that may prevent widespread use in health care settings. Quick and easy tools to obtain valid and reliable muscle strength outcomes in most clinical settings, including rehabilitation centers, are needed.</p><p>The sit-to-stand test (STST) represents a viable alternative for measuring peripheral muscle strength of the lower limbs.<xref rid="b13-copd-10-2423" ref-type="bibr">13</xref> Variations of the STST include the maximum number of times a subject can stand up and sit down on a regular chair in a given period of time, usually 30-seconds or 1-minute,<xref rid="b14-copd-10-2423" ref-type="bibr">14</xref>,<xref rid="b15-copd-10-2423" ref-type="bibr">15</xref> or the time taken to perform a given number of sit-to-stand maneuvers.<xref rid="b16-copd-10-2423" ref-type="bibr">16</xref> The STST can be performed in any health care setting, since it requires minimal equipment (conventional chair and stopwatch) and is easy and quick to perform for most subjects.</p><p>Accordingly, the aim of this study was to assess the peripheral muscle performance of the lower limbs in COPD patients by two STSTs (30-seconds and 1-minute), as compared to the 1-RM, and to evaluate the responsiveness of STSTs and 1-RM to a PR program with specific strength training (SPR), compared to usual PR program (UPR).</p></sec><sec sec-type="methods"><title>Methods</title><sec sec-type="methods"><title>Design of the study</title><p>Firstly, COPD patients were examined in a cross-sectional strategy, to compare 1-RM and the two STSTs in assessing lower muscle performance at baseline. Accordingly, on day 1 of the study, patients performed medical evaluation (medical history and physical examination), pulmonary function tests, and blood gas analysis. On the subsequent day, in the afternoon, patients performed a 6-minute walking test (6MWT) and 1-RM, with an interval of at least 2 hours between each test. On day 3, in the afternoon, patients performed the two STSTs, with an interval of at least 2 hours between each test.</p><p>Secondly, patients were randomly allocated into either the intervention group receiving SPR or into the UPR group. Before discharge, patients repeated functional assessments. Differences between initial and final values were calculated.</p><p>The study was approved by the Internal Review Board of the Institute of Care and Scientific Research Rehabilitation Institute of Tradate, Salvatore Maugeri Foundation, Tradate, Italy. The procedures were performed between January 7, 2014 to April 9, 2015.</p></sec><sec sec-type="subjects"><title>Subjects</title><p>We examined 60 patients with COPD who attended an inpatient PR program. The majority of patients were sedentary and housebound. Twenty-four out of 60 patients participated in a previous PR program, but all these patients were free from this PR program for at least 1 year and they were present in both intervention groups, without any statistically significant difference. Thirty subjects were randomly assigned into the SPR group and 30 in the UPR group, and the two groups matched for age, sex, and disease severity. All patients had a diagnosis for COPD according to the Global initiative for chronic Obstructive Lung Disease (GOLD) criteria.<xref rid="b17-copd-10-2423" ref-type="bibr">17</xref> Patients who had acute exacerbation over the previous 4 weeks were excluded. Patients who did not complete the PR program, for intercurrent COPD exacerbation, or any unstable medical condition, were also excluded. Contraindications for participation in the PR program included musculoskeletal disorders, malignant diseases, unstable cardiac condition, and lack of adherence to the program. All patients had a smoking history &#x02265;10 pack years and received regular treatment with inhaled bronchodilators and inhaled steroids according to current guidelines for their disease stage. Each patient signed an informed consent form.</p></sec><sec sec-type="methods"><title>Pulmonary function tests and arterial blood gas analysis</title><p>Vital capacity (VC), forced expiratory volume in 1 second (FEV<sub>1</sub>), total lung capacity (TLC), and residual volume (RV) were measured by means of a flow-sensing spirometer and a body plethysmograph connected to a computer for data analysis (Masterlab, Jaeger, Wurzburg, Germany). Transfer factor of the lung for carbon monoxide (<italic>T</italic>L,CO) was measured by the single breath method using a mixture of carbon monoxide and methane (Sensor Medics, Yorba Linda, USA). VC, FEV<sub>1</sub> TLC, RV, and <italic>T</italic>L,CO were expressed as a percentage of the predicted values, which were obtained from regression equations by Quanjer et al<xref rid="b18-copd-10-2423" ref-type="bibr">18</xref> and Cotes et al.<xref rid="b19-copd-10-2423" ref-type="bibr">19</xref> FEV<sub>1</sub>/VC and RV/TLC ratios were taken as indices of airway obstruction and lung hyperinflation, respectively.</p><p>Arterial partial pressure of oxygen and arterial partial pressure of carbon dioxide were measured immediately after sampling from a puncture of the radial artery (Gas analyzer ABL 330; Radiometer, Copenhagen, Denmark).</p></sec><sec><title>1-RM test</title><p>The 1-RM strength test was performed using a resistance weight-lifting machine (Leg Extension, Mod. Class 2Sc, Technogym, Cesena, Italy). Prior to muscular strength testing, all patients were instructed on the proper technique. Briefly, each subject was instructed in sitting position to extend both knees at the same time, starting from a 90&#x000b0; knee flexion position to a 180&#x000b0; extension, which works the thigh muscles, and especially the quadriceps. Prior to performing the 1-RM testing sessions, all participants underwent two familiarization sessions without any load. This 1-RM strength test was to determine the greatest amount of weight that the individual could move in a single repetition, with a random initial load that was increased or reduced in accordance with the individual&#x02019;s ability to perform a repetition; this could be repeated again, with a 1-minute interval between each load.<xref rid="b9-copd-10-2423" ref-type="bibr">9</xref></p></sec><sec><title>STST</title><p>A straight-backed armless chair with a hard seat was stabilized by placing it against a wall. Floor to seat height was 47 cm. Seated participants were asked to come forward on the seat until their feet were flat on the floor, and to fold their upper limbs across the chest. Participants were then instructed to stand up all the way and sit down once without using the upper limbs. Subjects started in the seated position on the chair and, upon command, stood up and then returned to sitting as many times as possible in a 30-second time period and in a 1-minute time period.<xref rid="b14-copd-10-2423" ref-type="bibr">14</xref>,<xref rid="b15-copd-10-2423" ref-type="bibr">15</xref></p></sec><sec><title>VAS fatigue</title><p>Immediately after 1-RM and STSTs, patients rated the magnitude of their perceived peripheral muscle fatigue to complete the test. We adopted an interval scale, which was a 100 mm horizontal visual analogue scale (VAS), ranging from 0 (no fatigue) to 100 (worst imaginable fatigue).<xref rid="b20-copd-10-2423" ref-type="bibr">20</xref> The subjects had to indicate their lower limbs muscle fatigue perception at the moment of the assessment.</p></sec><sec><title>Walking capacity</title><p>Walking capacity was evaluated by means of the distance covered during a 6MWT according to the American Thoracic Society (ATS) statement.<xref rid="b21-copd-10-2423" ref-type="bibr">21</xref> The 6MWT was performed by all patients in a 30 m indoor, level, hospital corridor, under the supervision of a physiotherapist, according to the ATS guidelines. All patients received the same instructions before the walk, and were encouraged by the physiotherapist who repeated set phrases every minute during the walk. A practice 6MWT was not performed. The distance covered during the test was recorded in meters. Patients were allowed to stop and rest during the test but were instructed to resume walking as soon as they felt able to do so.</p></sec><sec><title>PR program</title><p>The control and the intervention group received the UPR. According to the international recommendations, the PR program was completely tailored to suit the needs of the individual.<xref rid="b3-copd-10-2423" ref-type="bibr">3</xref> The program consisted of 15 sessions over a 3-week period. To be included in the study, patients had to perform at least 12 supervised sessions, up to a maximum of 15 sessions. Lower limb endurance training was the main component of the PR program. All patients performed sessions of 30&#x02013;40 minutes, using a treadmill or cycle-ergometer, depending on the clinically based choice of the physiotherapist, and on the subject&#x02019;s preference. Exercise intensity was based on the initial 6MWT, and patients started their training at 60%&#x02013;70% of the maximum heart rate (HR) achieved on the 6MWT.<xref rid="b22-copd-10-2423" ref-type="bibr">22</xref> Exercises were then adjusted based on patient tolerance (at least weekly) with the aim of achieving a Borg dyspnea score of 3&#x02013;5 (moderate&#x02013;severe). To optimize training load supplemental oxygen for patients with chronic respiratory failure and interval training for much compromised patients were adopted. Transcutaneous arterial oxygen saturation, arterial pressure, and HR were monitored during every exercise session. Each session also included supervised upper limb training; patients used an arm ergometer or performed callisthenic exercises holding a light weight. In relation to the patient&#x02019;s needs, the PR program could also include other components, such as airway clearance techniques, pursed lips breathing and exhalation on effort, and inspiratory muscle training using threshold loading devices. Finally, each patient participated in educational activities, individually (at least one time) and in a group (at least three times), regarding self-management, airway clearance techniques, adherence to therapy, and nutritional support. The total daily time duration for all activities was 2&#x02013;3 hours, and the entire program was conducted in the hospital.</p><p>In addition, the intervention group received a SPR of their peripheral muscles. The program consisted of two sets of seven different exercises, 12&#x02013;20 repetitions each. Initial loads were equivalent to either 60%&#x02013;70% of the 1-RM or one that evoked fatigue after 8&#x02013;12 repetitions. The exercise dosage was increased when the individual could perform the current workload for one or two repetitions over the requested number on two consecutive training sessions.</p></sec><sec sec-type="methods"><title>Statistical analysis</title><p>Continuous data are reported as mean &#x000b1; standard deviation, unless otherwise specified. The distribution of variables was assessed by means of the Kolmogorov-Smirnov Goodness-of-Fit test.<xref rid="b23-copd-10-2423" ref-type="bibr">23</xref> Given the exploratory nature of the study, we did not evaluate the effect size. Comparisons between quantitative and qualitative variables were determined by paired and unpaired <italic>t</italic>-tests, and <italic>&#x003c7;</italic><sup>2</sup> test, when appropriate. A statistical analysis by one way analysis of variance (ANOVA) was also performed to detect significant variations between groups, followed, where significant, by the Student&#x02019;s <italic>t</italic>-test with Bonferroni adjustment. Relationships between variables were assessed by the Pearson&#x02019;s correlation coefficient (<italic>r</italic>). The agreement between 1-RM and STSTs was assessed by the method of differences against the means according to Bland and Altman.<xref rid="b24-copd-10-2423" ref-type="bibr">24</xref> To minimize the relationship between differences and means, the difference between measures was expressed as percentage of the mean. A <italic>P</italic>-value &#x0003c;0.05 was considered as statistically significant.</p><p>Data analyses and graphical presentations were performed using GraphPad Prism 5 (GraphPad Software, San Diego, California, USA) and SPSS version 20 (IBM, Armonk, New York, USA).</p></sec></sec><sec sec-type="results"><title>Results</title><p>All patients completed the procedures without any dropout. Characteristics of patients at baseline are reported in <xref ref-type="table" rid="t1-copd-10-2423">Table 1</xref>. The two groups were comparable at baseline.</p><p>In all patients, at baseline 1-RM was significantly related to the 30-second STST (<italic>r</italic>=0.48; <italic>P</italic>&#x0003c;0.001) and to the 1-minute STST (<italic>r</italic>=0.36; <italic>P</italic>=0.005) (<xref ref-type="fig" rid="f1-copd-10-2423">Figure 1</xref>). Similarly, 6MWT was significantly related to the 30-second STST (<italic>r</italic>=0.44; <italic>P</italic>&#x0003c;0.001) and to the 1-minute STST (<italic>r</italic>=0.48; <italic>P</italic>&#x0003c;0.001). The relationship between baseline variables and the three outcomes evaluating peripheral muscle strength are shown in <xref ref-type="table" rid="t2-copd-10-2423">Table 2</xref>. Overall, the three outcome measures were directly related to airflow obstruction and negatively related to lung hyperinflation.</p><p>According to the Bland&#x02013;Altman plots, the biases (limits of agreement) between 1-RM and 30-second STST and between 1-RM and 1-minute STST were 26% (&#x02212;32%&#x02013;85%) and 80% (32%&#x02013;128%), respectively (<xref ref-type="fig" rid="f2-copd-10-2423">Figure 2</xref>).</p><p>By ANOVA there were statistically significant differences in VAS for fatigue among 1-RM, 30-second STST, and 1-minute STST (<italic>P</italic>=0.002). Post hoc analyses showed statistically significant differences between the perceived fatigue after 30-second STST (40&#x000b1;26) and those after both 1-RM (50&#x000b1;28) and 1-minute STST (58&#x000b1;26) (<italic>P</italic>=0.047 and <italic>P</italic>&#x0003c;0.001, respectively) (<xref ref-type="table" rid="t3-copd-10-2423">Table 3</xref>). The other comparisons between the three tests, regarding HR, oxygen saturation, and time required to complete the tests are shown in <xref ref-type="table" rid="t3-copd-10-2423">Table 3</xref>.</p><p>After PR, in the SPR group significant improvements were observed in 30-second STST (<italic>P</italic>&#x0003c;0.001), 1-minute STST (<italic>P</italic>=0.005), 1-RM (<italic>P</italic>&#x0003c;0.001), and 6MWT (<italic>P</italic>=0.001) whereas in the UPR group significant improvement was observed in 30-second STST (<italic>P</italic>=0.042) and 6MWT (<italic>P</italic>=0.001) (<xref ref-type="table" rid="t4-copd-10-2423">Table 4</xref>).</p><p>In the SPR group, the improvement in 30-second STST after PR, expressed as a percent change, but not in 1-minute STST, was directly correlated with the change in 1-RM (<italic>r</italic>=0.47; <italic>P</italic>=0.009).</p></sec><sec sec-type="discussion"><title>Discussion</title><p>In this study, we investigated the value of the STST in the assessment of the peripheral muscle strength of lower limbs, by comparing it to the 1-RM and by evaluating its responsiveness to a specific PR program in patients with stable moderate-to-severe COPD. The main result of this study was that in all patients, 30-second STST and 1-minute STST showed a significant correlation with 1-RM, considered as the gold standard for muscle strength assessing. Moreover, only the specific PR program was able to significantly improve the 30-second STST and 1-minute STST, and 1-RM. Finally, as compared to 1-minute STST and 1-RM, 30-second STST was better tolerated in terms of perceived fatigue and quicker to perform in terms of expenditure of time, including instructions to the patient.</p><p>It has been recognized that skeletal muscle dysfunction is a common feature in patients with COPD, and may play a significant role in morbidity and mortality.<xref rid="b25-copd-10-2423" ref-type="bibr">25</xref>,<xref rid="b26-copd-10-2423" ref-type="bibr">26</xref> Several studies have demonstrated that peripheral muscle weakness may be a major contributor to exercise limitation in COPD.<xref rid="b1-copd-10-2423" ref-type="bibr">1</xref>,<xref rid="b27-copd-10-2423" ref-type="bibr">27</xref> Although 1-RM is the most reliable test for evaluating the maximal strength of a muscle or group of muscles,<xref rid="b8-copd-10-2423" ref-type="bibr">8</xref>,<xref rid="b9-copd-10-2423" ref-type="bibr">9</xref> untrained subjects are not always able to reach their 1-RM.<xref rid="b25-copd-10-2423" ref-type="bibr">25</xref> Therefore, a familiarization process prior to 1-RM strength test is essential for ensuring reliable test results, and minimize learning effects or systematic bias.<xref rid="b28-copd-10-2423" ref-type="bibr">28</xref> Moreover, multiple familiarization sessions are needed to avoid an improvement in muscle strength due to improved motor coordination or other neural adaptations.<xref rid="b29-copd-10-2423" ref-type="bibr">29</xref> Despite being one of the most common tests used in clinical practice for exercise prescription in healthy subjects, proper assessment using 1-RM is time consuming and may lead to muscle fatigue.<xref rid="b30-copd-10-2423" ref-type="bibr">30</xref></p><p>The STST was found to be a reliable tool to assess lower body strength and performance<xref rid="b13-copd-10-2423" ref-type="bibr">13</xref>&#x02013;<xref rid="b16-copd-10-2423" ref-type="bibr">16</xref> and might be considered as an alternative tool to 1-RM.<xref rid="b14-copd-10-2423" ref-type="bibr">14</xref> Interestingly, Jones et al<xref rid="b14-copd-10-2423" ref-type="bibr">14</xref> determined the test-retest reliability of the 30-second chair stand, as a measure of lower body strength in 76 healthy older adults with a mean age of 74 years, and tested its validity by comparing chair-stand performance to 1-RM. They showed a good test-retest intraclass correlation and a highly significant correlation between chair-stand and 1-RM leg-press performance.<xref rid="b14-copd-10-2423" ref-type="bibr">14</xref> In addition, Takai et al evaluated 57 elderly healthy subjects with a mean age of 64 years and showed that a combined power index of a ten repeated STST, including time taken for the test, body mass and leg length, can assess the force-generating capacity of knee extensors.<xref rid="b31-copd-10-2423" ref-type="bibr">31</xref> However, to the best of our knowledge, no previous studies have so far been addressed to compare STST to 1-RM in COPD patients.</p><p>In the present study, we provided the first evidence of a significant correlation between STST and 1-RM knee-extension in a population of COPD clinically stable patients. Notably, the 30-second STST showed a better relationship with 1-RM than 1-minute STST. We also found that the 30-second STST was better tolerated and quicker to be performed by the patients. These findings may have some practical interest. Laboratory tests are expensive, labor intensive, and require specialist equipment and personnel. Moreover, unlike 1-RM, the STST maneuver is simpler, cheaper, and represents a common activity of daily living.</p><p>In addition, we demonstrated a significant relationship between lung function and the performance data of the three tests. Albeit with some differences among the three strength tests, the patients with a better preserved pulmonary function were associated with a higher lower limb strength performance. Previous studies showed discordant results.<xref rid="b15-copd-10-2423" ref-type="bibr">15</xref>,<xref rid="b16-copd-10-2423" ref-type="bibr">16</xref> No correlation between pulmonary function, expressed as FEV<sub>1</sub>, and lower limb strength performance, evaluated by 1-minute STST<xref rid="b15-copd-10-2423" ref-type="bibr">15</xref> or five repetition STST<xref rid="b16-copd-10-2423" ref-type="bibr">16</xref> was reported. On the other hand, Bernard et al found that quadriceps strength, measured during dynamic contractions against a hydraulic resistance, correlated positively with FEV<sub>1</sub> expressed as percentage of predicted.<xref rid="b32-copd-10-2423" ref-type="bibr">32</xref> Moreover, Seymour et al reported that the highest prevalence of quadriceps weakness, evaluated by isometric quadriceps maximum voluntary contraction strength, was found in COPD patients with the most severe airflow obstruction.<xref rid="b33-copd-10-2423" ref-type="bibr">33</xref></p><p>In this study, we found a significant improvement in all the three muscle strength outcomes in the intervention PR group of COPD patients, whereas the effect of conventional PR on lower limb muscle strength had a modest, even if significant change, only in 30-second STST. Previous studies compared the effects of strength and endurance training in patients with COPD, without using STST.<xref rid="b5-copd-10-2423" ref-type="bibr">5</xref>&#x02013;<xref rid="b7-copd-10-2423" ref-type="bibr">7</xref>,<xref rid="b34-copd-10-2423" ref-type="bibr">34</xref> Strength training has a greater potential to improve muscle mass and strength than endurance training.<xref rid="b5-copd-10-2423" ref-type="bibr">5</xref>,<xref rid="b6-copd-10-2423" ref-type="bibr">6</xref>,<xref rid="b34-copd-10-2423" ref-type="bibr">34</xref> Moreover, strength training induces less dyspnea during exercise, which most likely makes it easier to tolerate than with aerobic training.<xref rid="b7-copd-10-2423" ref-type="bibr">7</xref></p><p>Despite reporting original findings with potential clinical significance, this study has some limitations. We have to acknowledge that sit-to-stand performance can depend, in addition to strength, on sensation, balance, and psychological status, as showed in older people.<xref rid="b35-copd-10-2423" ref-type="bibr">35</xref> However, quadriceps strength was found to be an important factor in explaining a considerable part of the variance in sit-to-stand performance.<xref rid="b35-copd-10-2423" ref-type="bibr">35</xref> In this study, we evaluated a relatively small cohort of COPD patients. Interestingly, most of the previous studies enrolled similar numbers of patients,<xref rid="b9-copd-10-2423" ref-type="bibr">9</xref>&#x02013;<xref rid="b12-copd-10-2423" ref-type="bibr">12</xref>,<xref rid="b14-copd-10-2423" ref-type="bibr">14</xref>,<xref rid="b15-copd-10-2423" ref-type="bibr">15</xref>,<xref rid="b28-copd-10-2423" ref-type="bibr">28</xref>,<xref rid="b29-copd-10-2423" ref-type="bibr">29</xref>,<xref rid="b31-copd-10-2423" ref-type="bibr">31</xref>,<xref rid="b32-copd-10-2423" ref-type="bibr">32</xref>,<xref rid="b34-copd-10-2423" ref-type="bibr">34</xref> whereas few studies analyzed larger cohorts of patients.<xref rid="b16-copd-10-2423" ref-type="bibr">16</xref>,<xref rid="b25-copd-10-2423" ref-type="bibr">25</xref>,<xref rid="b35-copd-10-2423" ref-type="bibr">35</xref></p></sec><sec><title>Conclusion</title><p>In conclusion, STSTs correlated with quadriceps strength measured by 1-RM and were responsive to PR with SPR. The 30-second STST was better tolerated in terms of perceived fatigue and quicker to perform.</p></sec></body><back><ack><title>Acknowledgments</title><p>We gratefully acknowledge the technical assistance of Dr Daniele Ferrari and Davide Partegiani of the University of Insubria, Varese, Italy, with preparing the manuscript.</p></ack><fn-group><fn><p><bold>Author contributions</bold></p><p>AZ, MA, AA, AC, and AS contributed to design, drafting, and interpretation, FC and EZ collected data, AZ, FC, and EZ performed statistical analysis. All authors contributed to the revision of the paper and agree to be accountable for all aspects of the work.</p></fn><fn><p><bold>Disclosure</bold></p><p>All the authors concurred with the submission and they report no conflicts of interest in this work. No additional and/or external funding was used to support this study.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-copd-10-2423"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gosselink</surname><given-names>R</given-names></name><name><surname>Troosters</surname><given-names>T</given-names></name><name><surname>Decramer</surname><given-names>M</given-names></name></person-group><article-title>Peripheral muscle weakness contributes to exercise limitation in COPD</article-title><source>Am J Respir Crit Care Med</source><year>1996</year><volume>153</volume><issue>3</issue><fpage>976</fpage><lpage>980</lpage><pub-id pub-id-type="pmid">8630582</pub-id></element-citation></ref><ref id="b2-copd-10-2423"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>AL</given-names></name><name><surname>Killian</surname><given-names>KJ</given-names></name><name><surname>Summers</surname><given-names>E</given-names></name><name><surname>Jones</surname><given-names>NL</given-names></name></person-group><article-title>Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders</article-title><source>Am J Respir Crit Care Med</source><year>1995</year><volume>152</volume><issue>6 Pt 1</issue><fpage>2021</fpage><lpage>2031</lpage><pub-id pub-id-type="pmid">8520771</pub-id></element-citation></ref><ref id="b3-copd-10-2423"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spruit</surname><given-names>MA</given-names></name><name><surname>Singh</surname><given-names>SJ</given-names></name><name><surname>Garvey</surname><given-names>C</given-names></name><etal/></person-group><article-title>An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation</article-title><source>Am J Respir Crit Care Med</source><year>2013</year><volume>188</volume><issue>8</issue><fpage>e13</fpage><lpage>e64</lpage><pub-id pub-id-type="pmid">24127811</pub-id></element-citation></ref><ref id="b4-copd-10-2423"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gloeckl</surname><given-names>R</given-names></name><name><surname>Marinov</surname><given-names>B</given-names></name><name><surname>Pitta</surname><given-names>F</given-names></name></person-group><article-title>Pratical recommendations for exercise training in patients with COPD</article-title><source>Eur Respir Rev</source><year>2013</year><volume>22</volume><issue>128</issue><fpage>178</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">23728873</pub-id></element-citation></ref><ref id="b5-copd-10-2423"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spruit</surname><given-names>MA</given-names></name><name><surname>Gosselink</surname><given-names>R</given-names></name><name><surname>Troosters</surname><given-names>T</given-names></name><name><surname>De Paepe</surname><given-names>K</given-names></name><name><surname>Decramer</surname><given-names>M</given-names></name></person-group><article-title>Resistance versus endurance training in patients with COPD and peripheral muscle weakness</article-title><source>Eur Respir J</source><year>2002</year><volume>19</volume><issue>6</issue><fpage>1072</fpage><lpage>1078</lpage><pub-id pub-id-type="pmid">12108859</pub-id></element-citation></ref><ref id="b6-copd-10-2423"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega</surname><given-names>F</given-names></name><name><surname>Toral</surname><given-names>J</given-names></name><name><surname>Cejudo</surname><given-names>P</given-names></name><etal/></person-group><article-title>Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease</article-title><source>Am J Respir Crit Care Med</source><year>2002</year><volume>166</volume><issue>5</issue><fpage>669</fpage><lpage>674</lpage><pub-id pub-id-type="pmid">12204863</pub-id></element-citation></ref><ref id="b7-copd-10-2423"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>K</given-names></name><name><surname>Killian</surname><given-names>K</given-names></name><name><surname>McCartney</surname><given-names>N</given-names></name><name><surname>Stubbing</surname><given-names>DG</given-names></name><name><surname>Jones</surname><given-names>NL</given-names></name></person-group><article-title>Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation</article-title><source>Thorax</source><year>1992</year><volume>47</volume><issue>2</issue><fpage>70</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">1549826</pub-id></element-citation></ref><ref id="b8-copd-10-2423"><label>8</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kraemer</surname><given-names>W</given-names></name><name><surname>Fry</surname><given-names>A</given-names></name></person-group><article-title>Strength testing: Development and evaluation of methodology</article-title><person-group person-group-type="editor"><name><surname>Maud</surname><given-names>PJ</given-names></name><name><surname>Foster</surname><given-names>C</given-names></name></person-group><source>Physiological assessment of human fitness</source><edition>2nd ed</edition><publisher-loc>Champaign, IL</publisher-loc><publisher-name>Human Kinetics</publisher-name><year>1995</year><fpage>115</fpage><lpage>138</lpage></element-citation></ref><ref id="b9-copd-10-2423"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levinger</surname><given-names>I</given-names></name><name><surname>Goodman</surname><given-names>C</given-names></name><name><surname>Hare</surname><given-names>DL</given-names></name><name><surname>Jerums</surname><given-names>G</given-names></name><name><surname>Toia</surname><given-names>D</given-names></name><name><surname>Selig</surname><given-names>S</given-names></name></person-group><article-title>The reliability of the 1RM strength test for untrained middle-aged individuals</article-title><source>J Sci Med Sport</source><year>2009</year><volume>12</volume><issue>2</issue><fpage>310</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">18078784</pub-id></element-citation></ref><ref id="b10-copd-10-2423"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaelin</surname><given-names>ME</given-names></name><name><surname>Swank</surname><given-names>AM</given-names></name><name><surname>Adams</surname><given-names>KJ</given-names></name><name><surname>Barnard</surname><given-names>KL</given-names></name><name><surname>Berning</surname><given-names>JM</given-names></name><name><surname>Green</surname><given-names>A</given-names></name></person-group><article-title>Cardiopulmonary responses, muscle soreness, and injury during the one repetition maximum assessment in pulmonary rehabilitation patients</article-title><source>J Cardiopulm Rehabil</source><year>1999</year><volume>19</volume><issue>6</issue><fpage>366</fpage><lpage>372</lpage><pub-id pub-id-type="pmid">10609187</pub-id></element-citation></ref><ref id="b11-copd-10-2423"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marino</surname><given-names>DM</given-names></name><name><surname>Marrara</surname><given-names>KT</given-names></name><name><surname>Ike</surname><given-names>D</given-names></name><name><surname>De Oliveira</surname><given-names>AD</given-names><suffix>Jr</suffix></name><name><surname>Jamami</surname><given-names>M</given-names></name><name><surname>Di Lorenzo</surname><given-names>VA</given-names></name></person-group><article-title>Study of peripheral muscle strength and severity indexes in individuals with chronic obstructive pulmonary disease</article-title><source>Physiother Res Int</source><year>2010</year><volume>15</volume><issue>3</issue><fpage>135</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">20108234</pub-id></element-citation></ref><ref id="b12-copd-10-2423"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000e1;rquez-Mart&#x000ed;n</surname><given-names>E</given-names></name><name><surname>Ramos</surname><given-names>PC</given-names></name><name><surname>L&#x000f3;pez-Campos</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Components of physical capacity in patients with chronic obstructive pulmonary disease: relationship with phenotypic expression</article-title><source>Int J Chron Obstruct Pulmon Dis</source><year>2011</year><volume>6</volume><fpage>105</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">21407823</pub-id></element-citation></ref><ref id="b13-copd-10-2423"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohannon</surname><given-names>RW</given-names></name></person-group><article-title>Sit-to-stand test for measuring performance of lower extremity muscles</article-title><source>Percept Mot Skills</source><year>1995</year><volume>80</volume><issue>1</issue><fpage>163</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">7624188</pub-id></element-citation></ref><ref id="b14-copd-10-2423"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>CJ</given-names></name><name><surname>Rikli</surname><given-names>RE</given-names></name><name><surname>Beam</surname><given-names>WC</given-names></name></person-group><article-title>A 30-s chair-stand test as a measure of lower body strength in community-residing older adults</article-title><source>Res Q Exerc Sport</source><year>1999</year><volume>70</volume><issue>2</issue><fpage>113</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">10380242</pub-id></element-citation></ref><ref id="b15-copd-10-2423"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozalevli</surname><given-names>S</given-names></name><name><surname>Ozden</surname><given-names>A</given-names></name><name><surname>Itil</surname><given-names>O</given-names></name><name><surname>Akkoclu</surname><given-names>A</given-names></name></person-group><article-title>Comparison of the sit-to-stand test with 6 min walk test in patients with chronic obstructive pulmonary disease</article-title><source>Respir Med</source><year>2007</year><volume>101</volume><issue>2</issue><fpage>286</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">16806873</pub-id></element-citation></ref><ref id="b16-copd-10-2423"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>SE</given-names></name><name><surname>Kon</surname><given-names>SSC</given-names></name><name><surname>Canavan</surname><given-names>JL</given-names></name><etal/></person-group><article-title>The five-repetition sit-to-stand test as a functional outcome measure in COPD</article-title><source>Thorax</source><year>2013</year><volume>68</volume><issue>11</issue><fpage>1015</fpage><lpage>1020</lpage><pub-id pub-id-type="pmid">23783372</pub-id></element-citation></ref><ref id="b17-copd-10-2423"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vestbo</surname><given-names>J</given-names></name><name><surname>Hurd</surname><given-names>SS</given-names></name><name><surname>Agust&#x000ed;</surname><given-names>AG</given-names></name><etal/></person-group><article-title>Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary</article-title><source>Am J Respir Crit Care Med</source><year>2013</year><volume>187</volume><fpage>347</fpage><lpage>365</lpage><pub-id pub-id-type="pmid">22878278</pub-id></element-citation></ref><ref id="b18-copd-10-2423"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quanjer</surname><given-names>PH</given-names></name><name><surname>Tammeling</surname><given-names>GJ</given-names></name><name><surname>Cotes</surname><given-names>JE</given-names></name><name><surname>Pedersen</surname><given-names>OF</given-names></name><name><surname>Peslin</surname><given-names>R</given-names></name><name><surname>Yernault</surname><given-names>JC</given-names></name></person-group><article-title>Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society</article-title><source>Eur Respir J Suppl</source><year>1993</year><volume>16</volume><fpage>5</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">8499054</pub-id></element-citation></ref><ref id="b19-copd-10-2423"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cotes</surname><given-names>JE</given-names></name><name><surname>Chinn</surname><given-names>DJ</given-names></name><name><surname>Quanjer</surname><given-names>PH</given-names></name><name><surname>Roca</surname><given-names>J</given-names></name><name><surname>Yernault</surname><given-names>JC</given-names></name></person-group><article-title>Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society</article-title><source>Eur Respir J Suppl</source><year>1993</year><volume>16</volume><fpage>41</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">8499053</pub-id></element-citation></ref><ref id="b20-copd-10-2423"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stendardi</surname><given-names>L</given-names></name><name><surname>Grazzini</surname><given-names>M</given-names></name><name><surname>Gigliotti</surname><given-names>F</given-names></name><name><surname>Lotti</surname><given-names>P</given-names></name><name><surname>Scano</surname><given-names>G</given-names></name></person-group><article-title>Dyspnea and leg effort during exercise</article-title><source>Respir Med</source><year>2005</year><volume>99</volume><issue>8</issue><fpage>933</fpage><lpage>942</lpage><pub-id pub-id-type="pmid">15950133</pub-id></element-citation></ref><ref id="b21-copd-10-2423"><label>21</label><element-citation publication-type="journal"><comment>No author</comment><article-title>ATS statement: guidelines for the six-minute walk test. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories</article-title><source>Am J Respir Crit Care Med</source><year>2002</year><volume>166</volume><issue>1</issue><fpage>111</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">12091180</pub-id></element-citation></ref><ref id="b22-copd-10-2423"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zainuldin</surname><given-names>MR</given-names></name><name><surname>Knoke</surname><given-names>D</given-names></name><name><surname>Mackey</surname><given-names>MG</given-names></name><name><surname>Luxton</surname><given-names>N</given-names></name><name><surname>Alison</surname><given-names>JA</given-names></name></person-group><article-title>Prescribing cycle training intensity from the six-minute walk test for patients with COPD</article-title><source>BMC Pulm Med</source><year>2007</year><volume>7</volume><fpage>9</fpage><pub-id pub-id-type="pmid">17603916</pub-id></element-citation></ref><ref id="b23-copd-10-2423"><label>23</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chakravarti</surname><given-names>IM</given-names></name><name><surname>Laha</surname><given-names>RG</given-names></name><name><surname>Roy</surname><given-names>J</given-names></name></person-group><source>Handbook of Methods of Applied Statistics, Volume I</source><publisher-name>John Wiley and Sons</publisher-name><publisher-loc>Hoboken</publisher-loc><year>1967</year><fpage>392</fpage><lpage>394</lpage></element-citation></ref><ref id="b24-copd-10-2423"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bland</surname><given-names>JM</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name></person-group><article-title>Statistical methods for assessing agreement between two methods of clinical measurement</article-title><source>Lancet</source><year>1986</year><volume>1</volume><issue>8476</issue><fpage>307</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">2868172</pub-id></element-citation></ref><ref id="b25-copd-10-2423"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swallow</surname><given-names>EB</given-names></name><name><surname>Reyes</surname><given-names>D</given-names></name><name><surname>Hopkinson</surname><given-names>NS</given-names></name><etal/></person-group><article-title>Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease</article-title><source>Thorax</source><year>2007</year><volume>62</volume><issue>2</issue><fpage>115</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">17090575</pub-id></element-citation></ref><ref id="b26-copd-10-2423"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puhan</surname><given-names>MA</given-names></name><name><surname>Siebeling</surname><given-names>L</given-names></name><name><surname>Zoller</surname><given-names>M</given-names></name><name><surname>Muggensturm</surname><given-names>P</given-names></name><name><surname>ter Riet</surname><given-names>G</given-names></name></person-group><article-title>Simple functional performance tests and mortality in COPD</article-title><source>Eur Respir J</source><year>2013</year><volume>42</volume><issue>4</issue><fpage>956</fpage><lpage>963</lpage><pub-id pub-id-type="pmid">23520321</pub-id></element-citation></ref><ref id="b27-copd-10-2423"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debigar&#x000e9;</surname><given-names>R</given-names></name><name><surname>Maltais</surname><given-names>F</given-names></name></person-group><article-title>The major limitation to exercise performance in COPD is lower limb muscle dysfunction</article-title><source>J Appl Physiol (1985)</source><year>2008</year><volume>105</volume><issue>2</issue><fpage>751</fpage><lpage>753</lpage><pub-id pub-id-type="pmid">18678623</pub-id></element-citation></ref><ref id="b28-copd-10-2423"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braith</surname><given-names>RW</given-names></name><name><surname>Graves</surname><given-names>JE</given-names></name><name><surname>Leggett</surname><given-names>SH</given-names></name><name><surname>Pollock</surname><given-names>ML</given-names></name></person-group><article-title>Effect of training on the relationship between maximal and submaximal strength</article-title><source>Med Sci Sports Exerc</source><year>1993</year><volume>25</volume><issue>1</issue><fpage>132</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">8423746</pub-id></element-citation></ref><ref id="b29-copd-10-2423"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ploutz-Snyder</surname><given-names>LL</given-names></name><name><surname>Giamis</surname><given-names>EL</given-names></name></person-group><article-title>Orientation and familiarization to 1RM strength testing in old and young women</article-title><source>J Strength Cond Res</source><year>2001</year><volume>15</volume><issue>4</issue><fpage>519</fpage><lpage>523</lpage><pub-id pub-id-type="pmid">11726267</pub-id></element-citation></ref><ref id="b30-copd-10-2423"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robles</surname><given-names>PG</given-names></name><name><surname>Mathur</surname><given-names>S</given-names></name><name><surname>Janaudis-Fereira</surname><given-names>T</given-names></name><name><surname>Dolmage</surname><given-names>TE</given-names></name><name><surname>Goldstein</surname><given-names>RS</given-names></name><name><surname>Brooks</surname><given-names>D</given-names></name></person-group><article-title>Measurement of peripheral muscle strength in individuals with chronic obstructive pulmonary disease</article-title><source>J Cardiopulm Rehabil Prev</source><year>2011</year><volume>31</volume><issue>1</issue><fpage>11</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">20724932</pub-id></element-citation></ref><ref id="b31-copd-10-2423"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takai</surname><given-names>Y</given-names></name><name><surname>Ohta</surname><given-names>M</given-names></name><name><surname>Akagi</surname><given-names>R</given-names></name><name><surname>Kanehisa</surname><given-names>H</given-names></name><name><surname>Kawakami</surname><given-names>Y</given-names></name><name><surname>Fukunaga</surname><given-names>T</given-names></name></person-group><article-title>Sit-to-stand test to evaluate knee extensor muscle size and strength in the elderly: a novel approach</article-title><source>J Physiol Anthropol</source><year>2009</year><volume>28</volume><issue>3</issue><fpage>123</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">19483373</pub-id></element-citation></ref><ref id="b32-copd-10-2423"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernard</surname><given-names>S</given-names></name><name><surname>LeBlanc</surname><given-names>P</given-names></name><name><surname>Whittom</surname><given-names>F</given-names></name><etal/></person-group><article-title>Peripheral muscle weakness in patients with chronic obstructive pulmonary disease</article-title><source>Am J Respir Crit Care Med</source><year>1998</year><volume>158</volume><issue>2</issue><fpage>629</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">9700144</pub-id></element-citation></ref><ref id="b33-copd-10-2423"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seymour</surname><given-names>JM</given-names></name><name><surname>Spruit</surname><given-names>MA</given-names></name><name><surname>Hopkinson</surname><given-names>NS</given-names></name><etal/></person-group><article-title>The prevalence of quadriceps weakness in COPD and the relationship with disease severity</article-title><source>Eur Respir J</source><year>2010</year><volume>36</volume><issue>1</issue><fpage>81</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">19897554</pub-id></element-citation></ref><ref id="b34-copd-10-2423"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>WT</given-names></name><name><surname>Benton</surname><given-names>MJ</given-names></name><name><surname>Wagner</surname><given-names>CL</given-names></name><name><surname>Riley</surname><given-names>C</given-names></name></person-group><article-title>The effect of single set resistance training on strength and functional fitness in pulmonary rehabilitation patients</article-title><source>J Cardiopulm Rehabil</source><year>2006</year><volume>26</volume><issue>5</issue><fpage>330</fpage><lpage>337</lpage><pub-id pub-id-type="pmid">17003602</pub-id></element-citation></ref><ref id="b35-copd-10-2423"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lord</surname><given-names>SR</given-names></name><name><surname>Murray</surname><given-names>SM</given-names></name><name><surname>Chapman</surname><given-names>K</given-names></name><name><surname>Munro</surname><given-names>B</given-names></name><name><surname>Tiedemann</surname><given-names>A</given-names></name></person-group><article-title>Sit-to-stand performance depends on sensation, speed, balance, and psychological status in addition to strength in older people</article-title><source>J Gerontol A Biol Sci Med Sci</source><year>2002</year><volume>57</volume><issue>8</issue><fpage>M539</fpage><lpage>M543.35</lpage><pub-id pub-id-type="pmid">12145369</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-copd-10-2423" position="float"><label>Figure 1</label><caption><p>Relationship between the 1-RM and the two STSTs, 30-seconds (<italic>r</italic>=0.48, <italic>P</italic>&#x0003c;0.001) (<bold>A</bold>) and 1-minute (<italic>r</italic>=0.36, <italic>P</italic>=0.005) (<bold>B</bold>) at baseline in 60 COPD patients.</p><p><bold>Abbreviations:</bold> STST, sit-to-stand test; 1-RM, one-repetition maximum.</p></caption><graphic xlink:href="copd-10-2423Fig1"/></fig><fig id="f2-copd-10-2423" position="float"><label>Figure 2</label><caption><p>Plot of the percentage difference between 1-RM and 30-second STST against the mean of 1-RM and 30-second STST (<bold>A</bold>), and plot of the percentage difference between 1-RM and 1-minute STST against the mean of 1-RM and 1-minute STST (<bold>B</bold>) in 60 COPD patients.</p><p><bold>Abbreviations:</bold> STST, sit-to-stand test; 1-RM, one-repetition maximum.</p></caption><graphic xlink:href="copd-10-2423Fig2"/></fig><table-wrap id="t1-copd-10-2423" position="float"><label>Table 1</label><caption><p>Baseline characteristics of the two groups of COPD patients following SPR program and UPR program</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1">SPR group of patients (n=30)</th><th valign="top" align="left" rowspan="1" colspan="1">UPR group of patients (n=30)</th><th valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (years)</td><td valign="top" align="left" rowspan="1" colspan="1">69&#x000b1;5.8</td><td valign="top" align="left" rowspan="1" colspan="1">72&#x000b1;8</td><td valign="top" align="left" rowspan="1" colspan="1">0.143</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sex, female (%)</td><td valign="top" align="left" rowspan="1" colspan="1">5 (16.7)</td><td valign="top" align="left" rowspan="1" colspan="1">6 (20)</td><td valign="top" align="left" rowspan="1" colspan="1">0.738</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td valign="top" align="left" rowspan="1" colspan="1">25&#x000b1;4</td><td valign="top" align="left" rowspan="1" colspan="1">26&#x000b1;5</td><td valign="top" align="left" rowspan="1" colspan="1">0.165</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Smoking (pack years)</td><td valign="top" align="left" rowspan="1" colspan="1">53&#x000b1;31</td><td valign="top" align="left" rowspan="1" colspan="1">58&#x000b1;36</td><td valign="top" align="left" rowspan="1" colspan="1">0.571</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">FEV<sub>1</sub> (% pred)</td><td valign="top" align="left" rowspan="1" colspan="1">46&#x000b1;14</td><td valign="top" align="left" rowspan="1" colspan="1">51&#x000b1;16</td><td valign="top" align="left" rowspan="1" colspan="1">0.192</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">VC (% pred)</td><td valign="top" align="left" rowspan="1" colspan="1">81&#x000b1;16</td><td valign="top" align="left" rowspan="1" colspan="1">81&#x000b1;15</td><td valign="top" align="left" rowspan="1" colspan="1">0.918</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">FEV<sub>1</sub>/VC (%)</td><td valign="top" align="left" rowspan="1" colspan="1">40&#x000b1;12</td><td valign="top" align="left" rowspan="1" colspan="1">44&#x000b1;12</td><td valign="top" align="left" rowspan="1" colspan="1">0.269</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RV (% pred)</td><td valign="top" align="left" rowspan="1" colspan="1">191&#x000b1;48</td><td valign="top" align="left" rowspan="1" colspan="1">176&#x000b1;46</td><td valign="top" align="left" rowspan="1" colspan="1">0.211</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">TLC (% pred)</td><td valign="top" align="left" rowspan="1" colspan="1">129&#x000b1;20</td><td valign="top" align="left" rowspan="1" colspan="1">125&#x000b1;25</td><td valign="top" align="left" rowspan="1" colspan="1">0.540</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RV/TLC (%)</td><td valign="top" align="left" rowspan="1" colspan="1">61&#x000b1;9</td><td valign="top" align="left" rowspan="1" colspan="1">60&#x000b1;8</td><td valign="top" align="left" rowspan="1" colspan="1">0.793</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>T</italic>L,CO (% pred)</td><td valign="top" align="left" rowspan="1" colspan="1">52&#x000b1;13</td><td valign="top" align="left" rowspan="1" colspan="1">50&#x000b1;13</td><td valign="top" align="left" rowspan="1" colspan="1">0.433</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PaO<sub>2</sub> (mmHg)</td><td valign="top" align="left" rowspan="1" colspan="1">74&#x000b1;7</td><td valign="top" align="left" rowspan="1" colspan="1">71&#x000b1;7</td><td valign="top" align="left" rowspan="1" colspan="1">0.159</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PaCO<sub>2</sub> (mmHg)</td><td valign="top" align="left" rowspan="1" colspan="1">37&#x000b1;4</td><td valign="top" align="left" rowspan="1" colspan="1">38&#x000b1;5</td><td valign="top" align="left" rowspan="1" colspan="1">0.234</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Exacerbations previous year (n)</td><td valign="top" align="left" rowspan="1" colspan="1">1.1&#x000b1;1.3</td><td valign="top" align="left" rowspan="1" colspan="1">1.2&#x000b1;1.4</td><td valign="top" align="left" rowspan="1" colspan="1">0.902</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">1-RM (kg)</td><td valign="top" align="left" rowspan="1" colspan="1">33&#x000b1;7</td><td valign="top" align="left" rowspan="1" colspan="1">30&#x000b1;10</td><td valign="top" align="left" rowspan="1" colspan="1">0.212</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">1-minute STST (n)</td><td valign="top" align="left" rowspan="1" colspan="1">24&#x000b1;4</td><td valign="top" align="left" rowspan="1" colspan="1">23&#x000b1;5</td><td valign="top" align="left" rowspan="1" colspan="1">0.237</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">30-second STST (n)</td><td valign="top" align="left" rowspan="1" colspan="1">13&#x000b1;3</td><td valign="top" align="left" rowspan="1" colspan="1">13&#x000b1;2</td><td valign="top" align="left" rowspan="1" colspan="1">0.731</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">6MWT (m)</td><td valign="top" align="left" rowspan="1" colspan="1">450&#x000b1;84</td><td valign="top" align="left" rowspan="1" colspan="1">417&#x000b1;92</td><td valign="top" align="left" rowspan="1" colspan="1">0.154</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-copd-10-2423"><p><bold>Notes:</bold> Values are expressed as mean &#x000b1; SD or percent. Comparisons between variables were determined by unpaired <italic>t</italic>-test and <italic>&#x003c7;</italic><sup>2</sup> test. The two groups were matched for age, sex, and disease severity.</p></fn><fn id="tfn2-copd-10-2423"><p><bold>Abbreviations:</bold> SD, standard deviation; FEV<sub>1</sub>, forced respiratory volume in 1 second; VC, vital capacity; RV, residual volume; TLC, total lung capacity; <italic>T</italic>L,CO, transfer factor of the lung for carbon monoxide; BMI, body mass index; PaO<sub>2</sub>, arterial partial pressure of oxygen; PaCO<sub>2</sub>, arterial partial pressure of carbon dioxide; 1-RM, one-repetition maximum; STST, sit-to-stand test; 6MWT, 6-minute walking test; pred, predicted; SPR, specific pulmonary rehabilitation; UPR, usual pulmonary rehabilitation.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-copd-10-2423" position="float"><label>Table 2</label><caption><p>Relationship between baseline variables and the three outcomes of peripheral muscle strength, 30-second STST and 1-minute STST and 1-RM, in all study patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1">30-second STST</th><th valign="top" align="left" rowspan="1" colspan="1">1-minute STST</th><th valign="top" align="left" rowspan="1" colspan="1">1-RM</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (years)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=&#x02212;0.21; <italic>P</italic>=0.104</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=&#x02212;0.22; <italic>P</italic>=0.091</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=&#x02212;0.25; <italic>P</italic>=0.052</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=0.08; <italic>P</italic>=0.521</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=&#x02212;0.01; <italic>P</italic>=0.940</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=0.21; <italic>P</italic>=0.102</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Exacerbations previous year (n)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=0.01; <italic>P</italic>=0.914</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=&#x02212;0.04; <italic>P</italic>=0.765</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=&#x02212;0.15; <italic>P</italic>=0.267</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pack years (n)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=&#x02212;0.01; <italic>P</italic>=0.991</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=&#x02212;0.12; <italic>P</italic>=0.352</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=&#x02212;0.11; <italic>P</italic>=0.414</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">FEV<sub>1</sub> (% pred)</td><td valign="top" align="left" rowspan="1" colspan="1"><bold><italic>r</italic></bold>=<bold>0.38; <italic>P</italic></bold>=<bold>0.002</bold></td><td valign="top" align="left" rowspan="1" colspan="1"><bold><italic>r</italic></bold>=<bold>0.46; <italic>P</italic></bold>&#x0003c;<bold>0.001</bold></td><td valign="top" align="left" rowspan="1" colspan="1"><bold><italic>r</italic></bold>=<bold>0.38; <italic>P</italic></bold>=<bold>0.002</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">VC (% pred)</td><td valign="top" align="left" rowspan="1" colspan="1"><bold><italic>r</italic></bold>=<bold>0.37; <italic>P</italic></bold>=<bold>0.003</bold></td><td valign="top" align="left" rowspan="1" colspan="1"><bold><italic>r</italic></bold>=<bold>0.48; <italic>P</italic></bold>&#x0003c;<bold>0.001</bold></td><td valign="top" align="left" rowspan="1" colspan="1"><bold><italic>r</italic></bold>=<bold>0.37; <italic>P</italic></bold>=<bold>0.003</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">FEV<sub>1</sub>/VC</td><td valign="top" align="left" rowspan="1" colspan="1"><bold><italic>r</italic></bold>=<bold>0.26; <italic>P</italic></bold>=<bold>0.044</bold></td><td valign="top" align="left" rowspan="1" colspan="1"><bold><italic>r</italic></bold>=<bold>0.31; <italic>P</italic></bold>=<bold>0.015</bold></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=0.24; <italic>P</italic>=0.061</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RV (% pred)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=&#x02212;0.24; <italic>P</italic>=0.062</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=&#x02212;0.14; <italic>P</italic>=0.304</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=&#x02212;0.13; <italic>P</italic>=0.341</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">TLC (% pred)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=0.09; <italic>P</italic>=0.497</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=0.23; <italic>P</italic>=0.078</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=&#x02212;0.22; <italic>P</italic>=0.086</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RV/TLC</td><td valign="top" align="left" rowspan="1" colspan="1"><bold><italic>r</italic></bold>=&#x02212;<bold>0.36; <italic>P</italic></bold>=<bold>0.004</bold></td><td valign="top" align="left" rowspan="1" colspan="1"><bold><italic>r</italic></bold>=&#x02212;<bold>0.26; <italic>P</italic></bold>=<bold>0.042</bold></td><td valign="top" align="left" rowspan="1" colspan="1"><bold><italic>r</italic></bold>=&#x02212;<bold>0.49; <italic>P</italic></bold>&#x0003c;<bold>0.001</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>T</italic>L,CO (% pred)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=0.13; <italic>P</italic>=0.323</td><td valign="top" align="left" rowspan="1" colspan="1"><bold><italic>r</italic></bold>=<bold>0.38; <italic>P</italic></bold>=<bold>0.003</bold></td><td valign="top" align="left" rowspan="1" colspan="1"><bold><italic>r</italic></bold>=<bold>0.27; <italic>P</italic></bold>=<bold>0.035</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PaO<sub>2</sub> (mmHg)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=0.11; <italic>P</italic>=0.388</td><td valign="top" align="left" rowspan="1" colspan="1"><bold><italic>r</italic></bold>=<bold>0.27; <italic>P</italic></bold>=<bold>0.039</bold></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=0.03; <italic>P</italic>=0.809</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PaCO<sub>2</sub> (mmHg)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=&#x02212;0.06; <italic>P</italic>=0.629</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=&#x02212;0.12; <italic>P</italic>=0.356</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>=&#x02212;0.16; <italic>P</italic>=0.228</td></tr></tbody></table><table-wrap-foot><fn id="tfn3-copd-10-2423"><p><bold>Notes:</bold> Relationships between variables were assessed by the Pearson&#x02019;s correlation coefficient (<italic>r</italic>). Values in bold type significant correlations.</p></fn><fn id="tfn4-copd-10-2423"><p><bold>Abbreviations:</bold> FEV<sub>1</sub>, forced respiratory volume in 1 second; VC, vital capacity; RV, residual volume; TLC, total lung capacity; <italic>T</italic>L,CO, transfer factor of the lung for carbon monoxide; BMI, body mass index; PaO<sub>2</sub>, arterial partial pressure of oxygen; PaCO<sub>2</sub>, arterial partial pressure of carbon dioxide; 1-RM, one-repetition maximum; STST, sit-to-stand test.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-copd-10-2423" position="float"><label>Table 3</label><caption><p>Comparisons between the two STSTs and 1-RM with respect to VAS fatigue at the end of the test, HR, SpO<sub>2</sub>, and time required to complete the test</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1">30-second STST</th><th valign="top" align="left" rowspan="1" colspan="1">1-minute STST</th><th valign="top" align="left" rowspan="1" colspan="1">1-RM</th><th valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>-value<xref ref-type="table-fn" rid="tfn6-copd-10-2423">&#x000a7;</xref></th><th valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>-value<xref ref-type="table-fn" rid="tfn7-copd-10-2423">#</xref></th><th valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>-value<xref ref-type="table-fn" rid="tfn8-copd-10-2423">*</xref></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">VAS fatigue</td><td valign="top" align="left" rowspan="1" colspan="1">40&#x000b1;26</td><td valign="top" align="left" rowspan="1" colspan="1">58&#x000b1;26</td><td valign="top" align="left" rowspan="1" colspan="1">50&#x000b1;29</td><td valign="top" align="left" rowspan="1" colspan="1">0.047</td><td valign="top" align="left" rowspan="1" colspan="1">0.122</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HR at rest (bpm)</td><td valign="top" align="left" rowspan="1" colspan="1">83&#x000b1;13</td><td valign="top" align="left" rowspan="1" colspan="1">83&#x000b1;13</td><td valign="top" align="left" rowspan="1" colspan="1">82&#x000b1;13</td><td valign="top" align="left" rowspan="1" colspan="1">0.620</td><td valign="top" align="left" rowspan="1" colspan="1">0.847</td><td valign="top" align="left" rowspan="1" colspan="1">0.765</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HR max (bpm)</td><td valign="top" align="left" rowspan="1" colspan="1">101&#x000b1;13</td><td valign="top" align="left" rowspan="1" colspan="1">99&#x000b1;15</td><td valign="top" align="left" rowspan="1" colspan="1">92&#x000b1;14</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.001</td><td valign="top" align="left" rowspan="1" colspan="1">0.013</td><td valign="top" align="left" rowspan="1" colspan="1">0.382</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02206;HR (bpm)</td><td valign="top" align="left" rowspan="1" colspan="1">18&#x000b1;9</td><td valign="top" align="left" rowspan="1" colspan="1">16&#x000b1;11</td><td valign="top" align="left" rowspan="1" colspan="1">10&#x000b1;8</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.001</td><td valign="top" align="left" rowspan="1" colspan="1">0.412</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SpO<sub>2</sub> at rest</td><td valign="top" align="left" rowspan="1" colspan="1">95&#x000b1;2</td><td valign="top" align="left" rowspan="1" colspan="1">94&#x000b1;2</td><td valign="top" align="left" rowspan="1" colspan="1">94&#x000b1;2</td><td valign="top" align="left" rowspan="1" colspan="1">0.003</td><td valign="top" align="left" rowspan="1" colspan="1">0.713</td><td valign="top" align="left" rowspan="1" colspan="1">0.009</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SpO<sub>2</sub> (min)</td><td valign="top" align="left" rowspan="1" colspan="1">93&#x000b1;2</td><td valign="top" align="left" rowspan="1" colspan="1">92&#x000b1;3</td><td valign="top" align="left" rowspan="1" colspan="1">92&#x000b1;2</td><td valign="top" align="left" rowspan="1" colspan="1">0.019</td><td valign="top" align="left" rowspan="1" colspan="1">0.428</td><td valign="top" align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02206;SpO<sub>2</sub></td><td valign="top" align="left" rowspan="1" colspan="1">2&#x000b1;1.8</td><td valign="top" align="left" rowspan="1" colspan="1">2.6&#x000b1;2</td><td valign="top" align="left" rowspan="1" colspan="1">2&#x000b1;1.5</td><td valign="top" align="left" rowspan="1" colspan="1">0.911</td><td valign="top" align="left" rowspan="1" colspan="1">0.103</td><td valign="top" align="left" rowspan="1" colspan="1">0.157</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Time (sec)</td><td valign="top" align="left" rowspan="1" colspan="1">120&#x000b1;32</td><td valign="top" align="left" rowspan="1" colspan="1">164&#x000b1;46</td><td valign="top" align="left" rowspan="1" colspan="1">491&#x000b1;145</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn id="tfn5-copd-10-2423"><p><bold>Notes:</bold> Values are expressed as mean &#x000b1; SD. Comparisons between variables were determined by ANOVA, followed by the Student&#x02019;s <italic>t</italic>-tests with Bonferroni adjustment.</p></fn><fn id="tfn6-copd-10-2423"><label>&#x000a7;</label><p>30-second STST vs 1-RM;</p></fn><fn id="tfn7-copd-10-2423"><label>#</label><p>1-minute STST vs 1-RM;</p></fn><fn id="tfn8-copd-10-2423"><label>*</label><p>30-second STST vs 1-minute STST.</p></fn><fn id="tfn9-copd-10-2423"><p><bold>Abbreviations:</bold> 1-RM, one-repetition maximum; STST, sit-to-stand test; 6MWT, 6-minute walking test; VAS, visual analogic scale; HR, heart rate; SpO<sub>2</sub>, oxygen saturation; SD, standard deviation; vs, versus; &#x02206;HR, change after test in heart rate; &#x02206;SpO<sub>2</sub>, oxygen saturation.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4-copd-10-2423" position="float"><label>Table 4</label><caption><p>Response to PR in the COPD patients following the SPR program and the UPR program</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top" align="left" colspan="1">Outcome</th><th colspan="3" valign="top" align="left" rowspan="1">SPR group (n=30)
<hr/></th><th colspan="3" valign="top" align="left" rowspan="1">UPR group (n=30)
<hr/></th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">Pre-PR</th><th valign="top" align="left" rowspan="1" colspan="1">Post-PR</th><th valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>-value</th><th valign="top" align="left" rowspan="1" colspan="1">Pre-PR</th><th valign="top" align="left" rowspan="1" colspan="1">Post-PR</th><th valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">1-RM (kg)</td><td valign="top" align="left" rowspan="1" colspan="1">33&#x000b1;7</td><td valign="top" align="left" rowspan="1" colspan="1">43&#x000b1;13</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.001</td><td valign="top" align="left" rowspan="1" colspan="1">30&#x000b1;10</td><td valign="top" align="left" rowspan="1" colspan="1">32v10</td><td valign="top" align="left" rowspan="1" colspan="1">0.086</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">1-minute STST (n)</td><td valign="top" align="left" rowspan="1" colspan="1">24&#x000b1;4</td><td valign="top" align="left" rowspan="1" colspan="1">26&#x000b1;6</td><td valign="top" align="left" rowspan="1" colspan="1">0.005</td><td valign="top" align="left" rowspan="1" colspan="1">23&#x000b1;5</td><td valign="top" align="left" rowspan="1" colspan="1">24&#x000b1;7</td><td valign="top" align="left" rowspan="1" colspan="1">0.111</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">30-second STST (n)</td><td valign="top" align="left" rowspan="1" colspan="1">13&#x000b1;3</td><td valign="top" align="left" rowspan="1" colspan="1">15&#x000b1;3</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.001</td><td valign="top" align="left" rowspan="1" colspan="1">13&#x000b1;2</td><td valign="top" align="left" rowspan="1" colspan="1">14&#x000b1;3</td><td valign="top" align="left" rowspan="1" colspan="1">0.042</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">6MWT (m)</td><td valign="top" align="left" rowspan="1" colspan="1">450&#x000b1;84</td><td valign="top" align="left" rowspan="1" colspan="1">479&#x000b1;89</td><td valign="top" align="left" rowspan="1" colspan="1">0.001</td><td valign="top" align="left" rowspan="1" colspan="1">417&#x000b1;92</td><td valign="top" align="left" rowspan="1" colspan="1">454&#x000b1;8</td><td valign="top" align="left" rowspan="1" colspan="1">0.001</td></tr></tbody></table><table-wrap-foot><fn id="tfn10-copd-10-2423"><p><bold>Notes:</bold> Values are expressed as mean &#x000b1; SD. Comparisons between variables were determined by paired <italic>t</italic>-test.</p></fn><fn id="tfn11-copd-10-2423"><p><bold>Abbreviations:</bold> 1-RM, one-repetition maximum; STST, sit-to-stand test; 6MWT, 6-minute walking test; PR, pulmonary rehabilitation; SD, standard deviation; SPR, specific pulmonary rehabilitation; UPR, usual pulmonary rehabilitation.</p></fn></table-wrap-foot></table-wrap></floats-group></article>